DR. DAVID H FEIGLIN M.D. NPI 1275525891

NPI Details

DR. David H Feiglin, M.D. is a nuclear medicine in Syracuse, NY with 59 years of experience. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone DR. David H Feiglin, M.D. NPI is 1275525891. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

750 E ADAMS ST
3RD FLOOR RADIOLOGY
SYRACUSE, NY
ZIP 13210-306
Phone: (315) 464-6672

The NPI 1275525891 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)

The enumeration date for this NPI number is 8/19/2005 and was last updated on 3/17/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.